Literature DB >> 10931367

Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies.

J P Rossiter1, L L Anderson, F Yang, G M Cole.   

Abstract

Hirano bodies are eosinophilic rod-like inclusions that are found predominantly in neuronal processes in the hippocampal CA1 sector with increasing age and are particularly numerous in Alzheimer's disease. They contain a variety of cytoskeletal epitopes, especially actin and actin-binding proteins. Actin cleavage by cysteinyl aspartate-specific proteases (caspases) is a feature of apoptosis. Cleavage at aspartate 244 generates N-terminal 32 kDa and C-terminal 15 kDa actin fragments. This has led to the development of a rabbit polyclonal antibody specific for caspase-cleaved actin, directed to the last five C-terminal amino acids of the 32 kDa fragment of actin ('fractin'). Fractin immunohistochemistry was performed on hippocampal sections from Alzheimer's disease and control cases containing numerous Hirano bodies, in addition to immunolabelling with CM1 antiserum which recognizes activated caspase-3. The Hirano bodies showed strong diffuse fractin immunoreactivity. They did not label with CM1 antiserum, perhaps reflecting too low a level of activated caspase-3 for immunodetection, or involvement of a different member of the caspase family. The finding of fractin immunoreactivity of Hirano bodies suggests that caspase-like cleavage of actin may play a role in their formation and further supports caspase-like activity in neuronal processes, distinct from that associated with acute perikaryal apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931367     DOI: 10.1046/j.1365-2990.2000.00252.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  9 in total

Review 1.  Neuropathological alterations in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew P Frosch; Eliezer Masliah; Bradley T Hyman
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

2.  Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.

Authors:  Frédéric Calon; Giselle P Lim; Fusheng Yang; Takashi Morihara; Bruce Teter; Oliver Ubeda; Phillippe Rostaing; Antoine Triller; Norman Salem; Karen H Ashe; Sally A Frautschy; Greg M Cole
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

3.  Targets of caspase-6 activity in human neurons and Alzheimer disease.

Authors:  Guy Klaiman; Tracy L Petzke; Jennifer Hammond; Andréa C Leblanc
Journal:  Mol Cell Proteomics       Date:  2008-05-16       Impact factor: 5.911

4.  Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.

Authors:  Troy T Rohn
Journal:  Brain Res       Date:  2008-07-02       Impact factor: 3.252

Review 5.  Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspases.

Authors:  Troy T Rohn
Journal:  Histol Histopathol       Date:  2009-08       Impact factor: 2.303

6.  Degeneration of axotomized projection neurons in the rat dLGN: temporal progression of events and their mitigation by a single administration of FGF2.

Authors:  Michael L Hendrickson; Changying Ling; Ronald E Kalil
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

7.  Caspase-mediated cleavage of actin and tubulin is a common feature and sensitive marker of axonal degeneration in neural development and injury.

Authors:  Jennifer D Sokolowski; Kanchana K Gamage; Daniel S Heffron; Andrea C Leblanc; Christopher D Deppmann; James W Mandell
Journal:  Acta Neuropathol Commun       Date:  2014-02-07       Impact factor: 7.801

Review 8.  Non-Canonical Roles of Apoptotic Caspases in the Nervous System.

Authors:  Mahshid H Dehkordi; Robert G K Munn; Howard O Fearnhead
Journal:  Front Cell Dev Biol       Date:  2022-02-23

9.  Spatial learning depends on both the addition and removal of new hippocampal neurons.

Authors:  David Dupret; Annabelle Fabre; Màtè Dàniel Döbrössy; Aude Panatier; José Julio Rodríguez; Stéphanie Lamarque; Valerie Lemaire; Stephane H R Oliet; Pier-Vincenzo Piazza; Djoher Nora Abrous
Journal:  PLoS Biol       Date:  2007-08       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.